Evidence map›Paper›PMID 39707644›Full record

ArticlePharmacology research & perspectives2025

Are We Estimating the Mean and Variance Correctly in the Presence of Observations Outside of Measurable Range?

Markéta Janošová, Stanislav Katina, Jozef Hanes

Abstract read
In one paragraph

Article in Pharmacology research & perspectives, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Markéta JanošováDepartment of Mathematics and Statistics, Masaryk University Faculty of Science, Brno, Czech Republic.ORCID 0000-0002-4573-9226
Stanislav KatinaDepartment of Mathematics and Statistics, Masaryk University Faculty of Science, Brno, Czech Republic.
Jozef HanesSlovak Academy of Sciences Institute of Neuroimmunology, Bratislava, Slovakia.

Funding

Masarykova Univerzita MUNI/A/1457/2023
6 · The paper itself

Abstract

Laboratory measurements used for safety assessments in clinical trials are subject to the limits of the used laboratory equipment. These limits determine the range of values which the equipment can accurately measure. When observations fall outside the measurable range, this creates a problem in estimating parameters of the normal distribution. It may be tempting to use methods of estimation that are easy to implement, however selecting an incorrect method may lead to biased estimates (under- or overestimation) and change the research outcomes, for example, incorrect result of two-sample test about means when comparing two populations or biased estimation of regression line. In this article, we consider the use of four methods: ignoring unmeasured observations, replacing unmeasured observations with a multiple of the limit, using a truncated normal distribution, and using a normal distribution with censored observations. To compare these methods we designed a simulation study and measured their accuracy in several different situations using relative error

Indexed as

Computer SimulationBiasClinical Trials as TopicData Interpretation, StatisticalHumansModels, StatisticalNormal DistributionResearch Designclinical trialestimation techniqueslimit of detectionlimit of quantitationmeasurable rangesimulation study

Identifiers

PMID39707644
PMCPMC11661985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.